Conférences  >  Sciences biologiques  >  Biologie moléculaire  >  Suisse

ESMO - European Society for Medical Oncology

The ESMO Sarcoma and Rare Cancers Congress 2025 promises to be an excellent platform for the exchange of cutting-edge research, innovative therapeutic approaches, and collaborative discussions aimed at advancing this field of oncology. Mark your calendars for 20 – 22 March 2025, as we converge in the picturesque city of Lugano, Switzerland, renowned for its scenic beauty and vibrant culture. The ESMO Sarcoma and Rare Cancers Congress 2025 scientific and educational programme will delve into the latest developments in diagnosis, treatment modalities, biology, and molecular classification of rare solid tumours, offering attendees a comprehensive overview of the rapidly evolving landscape in this specialised area.

Meetings Operations team;     Tél.: [+41 91 97 31 946];     Email.: meetings@esmo.org

sarcoma, rare cancers, oncology, cancer treatment, precision medicine, immunotherapy, soft tissue sarcomas, bone sarcomas, clinical trials, multidisciplinary care, cancer research, pediatric oncology, advanced therapies, targeted therapy, patient care, innovative treatments, rare tumors, genetic profiling, cancer biomarkers, molecular oncology, survivorship, personalised medicine, global oncology, treatment guidelines, research collaborations, healthcare professionals, drug development, radiation oncology, surgical oncology

Cancérologie,    Biologie

MDPI

Participation in ECM 2025 is free of charge for both authors and attendees. This conference provides an excellent platform for researchers to present their latest findings, engage in direct discussions, and participate in online Q&A sessions. All submitted abstracts will be reviewed by the conference committee. Upon acceptance, authors will be asked to contribute an extended abstract for the conference proceedings and a slide presentation of their work. Authors of the most outstanding contributions will be invited to submit a full manuscript for potential publication in Microorganisms.

Email.: ecm2025@mdpi.com

S1. Gut Microbiota and Health Disease; S2. Foodborne Pathogens and Food Safety; S3. Antimicrobial Agents and Resistance; S4. Emerging Infectious Diseases; S5. Microbiome and Soil Science; S6. Microbial Characterization and Bioprocess; S7. Microbe–Plant Interactions;

European Molecular Biology Organization (EMBO)

European Molecular Biology Organization (EMBO)